IP Library Assignment 038866/0692
Patent Assignment
Reel/Frame 038866/0692

Assignment of Assignor's Interest

Recorded: 2016-06-09 Pages: 4
Assignors
BOSS, CHRISTOPH
Executed: 2016-05-10
BROTSCHI, CHRISTINE
Executed: 2016-05-10
GUDE, MARKUS
Executed: 2016-05-10
HEIDMANN, BIBIA
Executed: 2016-05-10
SIFFERLEN, THIERRY
Executed: 2016-05-10
VON RAUMER, MARKUS
Executed: 2016-05-10
WILLIAMS, JODI T.
Executed: 2016-05-10
Assignee
ACTELION PHARMACEUTICALS LTD.
GEWERBESTRASSE 16, ALLSCHWIL, CH-4123, SWITZERLAND
Covered Property (1)
Crystalline Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1 -Yl)(5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone and Its Use as Orexin Receptor Antagonists
Patent: 9,914,720 →
Application: 15/101,768 →
Publication: US 2016/0368901
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 13, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 042464/0407 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042464 Frame: 0407. Assignor(S) Hereby Confirms the Assignment. Jun 28, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 043017/0022 →